Neos S&P 500(R) High Inco... (SPYI)

Medicare's 2026 drug cap sounds like protection until you realize you fund the first $2,100 yourself, and a bad refill month can drain that before summer. Three ETFs can quietly cover that bill withou...

<p>Small-caps lagged their large-cap peers for over a decade in an environment dominated by the Fed put, failing to manifest any long lasting outperformance. With so much now changed, can small-cap pe...

SPYI's eye-catching monthly payouts hide a tax mechanic that quietly rewrites your cost basis every single distribution, and investors who spend the checks without tracking the paperwork could face a ...

Real estate is finally roaring back, but the same fund that carried investors through years of rate pain now looks like the wrong tool for collecting that recovery as cash. A newer REIT fund from the ...

Selling shares to fund retirement works fine until a market crash forces you to liquidate at the worst possible moment. Three covered-call ETFs offer a completely different income strategy, but pickin...